JKJennifer M. Kwan

Jennifer M. Kwan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jennifer M. Kwan has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytokine Signatures of Immune Checkpoint Inhibitor Myocarditis and the Modifying Role of Clonal Hematopoiesis: A Machine-Learning and Multi-Omics Study

    by Rachel Jaber Chehayeb, Nancy Manchanda, Dat Hong, Akarvin Jeyashanmugaraja, Jaiveer Singh, James L Cross, Avnith Vijayram, Carlos Matute Martinez, Ritujith Jayakrishnan, Anthos Christofides, et al.

    Background: Immune checkpoint inhibitor (ICI) myocarditis affects up to 2% of patients on ICI and has up to a 50% mortality. Clonal Hematopoiesis of Indeterminate Potential (CHIP) is a risk factor for ICI myocarditis. Objectives: To leverage a multi-omics approach to evaluate cytokines associated with ICI myocarditis, immunosuppression resistance, CHIP in ICI myocarditis and implicated pathways and cell type contributions. Methods: 236 cardio-oncology patients were enrolled, including 88 who were on ICI. Cytokine profiling from patients on ICI were sampled and analyzed using machine learning and explainable artificial intelligence. Single-cell multi-omics of peripheral blood from Yale (n=19), Stanford (n=25), and MGH (n=63) evaluated cell-type contributions of cytokines and implicated pathways. Validation of Yale proteomic analyses was done using the Stanford CYTOF dataset. Results: Top features associated with ICI myocarditis included IL13, CXCL10, PDGF-A, CCL13, CCL17 and KITlg. Top KEGG pathways associated with ICI myocarditis and immunosuppression resistant ICI myocarditis included JAK-STAT signaling, IL17 signaling and lipid/atherosclerosis pathways. At the single-cell level, the consensus signals distinguishing myocarditis from non-myocarditis across cohorts was predominantly driven by module-level JAK-STAT, T-cell, and Toll-like receptor activation. Similar transcription gene programs were activated in CHIP carriers including modules implicated in the pro-inflammatory immune response, such as NF-kappa B, IL17, MAPK, and TNF pathways within CHIP cells spanning lymphoid (cytotoxic CD8+ NKT, and natural killer cells) and myeloid lineages. Conclusions: Across cohorts, JAK-STAT signaling emerges as a convergent and potentially actionable axis in ICI myocarditis that is further amplified in CHIP carriers, supporting cytokine-guided risk stratification and JAK-STAT–directed immunosuppression as testable strategies.

  • Open Access

    Career Intentions and Research-Environment Factors Across the Physician-Scientist Pipeline

    by Sanaea Z Bhagwagar, Abdelrahman Abushouk, John Dempsey, Daniel C Brock, Aleksandar Obradovic, Alisha Faraz, James L Cross, Aisha Siebert, Han Naung Tun, Kevin M Lin, et al.

    Importance: Physician-scientist careers depend on sustained research funding, protected time, and institutional resources. However, data on career-retention attitudes across career stages are limited. Objective: To characterize career intentions and associated research-environment factors among MD-PhD students and early-career physician-scientists. Design: Two independent, national cross-sectional surveys were conducted during nonoverlapping periods in 2025; MD-PhD applicant and matriculant trends were also examined. Setting: Medical schools and academic health centers in the United States. Participants: MD-PhD students and early-career physician-scientists (ECPS). Exposures: MD-PhD exposures included perceived institutional support, training-related mental health impact, and research disruption. ECPS exposures included institutional support, adverse funding-related wellbeing, and direct National Institutes of Health funding-process disruption. Main Outcome and Measures: Primary outcomes were consideration of leaving the physician-scientist pathway among MD-PhD students and consideration of leaving academic medicine or research among ECPS. Secondary outcomes included likelihood of staying in academic medicine, research-intensive career preference, and consideration for leaving the US to continue research. Results: Among MD-PhD programs confirmed to have distributed the survey, 838 student responses were received (estimated response rate of 19.3%); 175 ECPS responses were received, with no calculable individual-level response rate. Among MD-PhD students, 423 of 835 (50.7%) reported considering leaving the physician-scientist pathway; 712 of 837 (85.1%) reported a high likelihood of remaining in academic medicine, and 664 of 836 (79.4%) preferred a research-intensive career. Adequate institutional support was associated with lower odds of considering leaving (adjusted odds ratio [aOR], 0.28; 95% CI, 0.14-0.54) and higher odds of staying in academic medicine (aOR, 5.65; 95% CI, 2.91-10.98). Training-related mental health impact (aOR, 2.34; 95% CI, 1.72-3.19) and research disruption (aOR, 1.83; 95% CI, 1.35-2.48) were associated with greater odds of considering leaving. Among ECPS, 57.7% considered leaving, 52.6% reported a high likelihood of staying, and 42.9% considered leaving the United States to continue research. Adverse funding-related well-being was associated with considering leaving academic medicine (aOR, 3.13; 95% CI, 1.52-6.63) and leaving the United States to continue research (aOR, 5.29; 95% CI, 2.35-13.12). Conclusions and Relevance: Consideration of leaving was common despite continued interest in academic and research-intensive careers. Institutional support, adverse well-being, and research disruptions were associated with career intentions.

  • Open Access

    Challenges Facing Early-Career Physician–Scientists in the United States Amid Recent Policy Shifts: Findings from a National Survey

    by Abdelrahman Abushouk, Aleksander Obradovic, Alisha Faraz, Aisha Siebert, Han Naung Tun, Evan Noch, Jennifer M Kwan

    Background: Amid persistent structural barriers and recent national policy changes, early-career physician–scientists face mounting challenges that threaten the sustainability of the biomedical research pipeline in the United States. Methods: We surveyed early career physician-scientists collecting demographic data, career development support, distribution of clinical and research responsibilities, funding, and perceived career challenges. The survey was distributed by email to the department chairs at 110 institutions in the United States. Results: A total of 175 surveys were completed. About half 50.8% (n=89) of respondents received a career development award, with 28.9% of respondents reporting limited institutional/departmental support. The most reported challenges were balancing clinical, research, and educational responsibilities (72.5%, n=127); balancing work and family responsibilities (48%, n= 84); limited funding opportunities (48%, n=84); and under-compensation (34.3%, n=60). About 57.7% (n=101) of respondents had considered leaving academic medicine within the next two years, and 83.2% (n=139) indicated a >50% likelihood of doing so within five years. The most frequently cited reasons for attrition were funding challenges (72%, n=126), under-compensation (42.3%, n=74), feeling unhappy or stressed (40.6%, n=71), and burnout (37.7%, n=66). Furthermore, 43.9% (n=76) of respondents reported considering relocation outside the United States for better academic working conditions, and 10.4% (n=18) had already been contacted by institutions abroad. Conclusion: Early-career physician–scientists face substantial structural and financial challenges, with limited institutional support, high rates of burnout, and widespread intent to leave academia. These findings underscore an urgent need for sustained investment, targeted retention strategies, and policy reforms to stabilize and strengthen the physician–scientist workforce in the United States.


  • Open Access

    Clonal Hematopoiesis Risk Score (CHRS) Evaluation as a Prognostic Marker for Death in Cardio-Oncology Cohort

    by Jaiveer Singh, Rachel Jaber Chehayeb, Yunju Im, Irvin Yi, Talal El Zarif, Ana Ferrigno Guajardo, Jennifer VanOudenhove, Stephanie Halene, Alok Jha, Jennifer M. Kwan


  • Open Access

    Correction: Evaluating factors impacting early career physician-scientists’ decisions to continue research careers in the United States of America

    by Kassem Farhat, Aleksandar Obradovic, Aisha Siebert, Han Naung Tun, Evan K. Noch, Jennifer M. Kwan


  • Open Access

    Evaluating factors impacting early career physician-scientists’ decisions to continue research careers in the United States of America

    by Kassem Farhat, Aleksandar Obradovic, Aisha Siebert, Han Naung Tun, Evan K. Noch, Jennifer M. Kwan

    Background: Bridging the gap between laboratory discoveries and patient care relies heavily on the physician-scientist workforce, which has historically served as a cornerstone in advancing biomedical sciences. However, the past decade has witnessed a remarkable decline in the number of emerging physician-scientists, raising concerns about the future of this vital community. This study aimed to evaluate the current state of early career physician-scientists on a national scale and explore challenges that hinder its growth, thereby limiting potential scientific innovation and progress. Methods: A survey was conducted in the United States and distributed to 110 nationally representative institutions using an online platform (SurveyMonkey), targeting physician-scientists at their late stage of clinical training (residents/fellows) and graduates of training programs within the past 10 years. 265 submitted results but after filtering for incomplete responses, a total of 230 survey results were used in the analysis. The survey evaluated scientific career trajectories, challenges encountered, and top priorities. Statistical analyses, including Chi-square and Fisher’s exact tests, were used to compare differences between groups. Results: A total of 230 physician-scientists completed the survey. The respondents were predominantly assistant professors (46%), while 27% were still enrolled in career training programs. Nearly half of the participants reported considering leaving their research career within the next two years. The primary reasons cited for this included burnout and unhappiness (35%), stress (35%), and lack of funding (30%). The most frequently reported career challenges were achieving a balance between clinical and educational responsibilities (63%) and maintaining work-life balance (53%), followed by insufficient research funding (41%). Additionally, participants underscored key factors they prioritize when seeking employment, including hybrid research-clinical opportunities (67%), work-life balance (52%), and financial security (26%). Conclusion: This national survey provides an overview of the current state of early-career physician-scientists. It examines the factors contributing to the inclination to leave the scientific track and identifies the primary career challenges faced by this vulnerable community. Furthermore, it highlights key priorities of physician-scientists and gaps that require attention, offering valuable insights into strategies for retaining and supporting this critical workforce.


  • Open Access

    Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort

    by Rachel Jaber Chehayeb, Jaiveer Singh, Carlos Matute-Martinez, Nathan W. Chen, Ana Ferrigno Guajardo, Derrick Lin, Ritujith Jayakrishnan, Anthos Christofides, Etienne Leveille, Yunju Im, et al.

    Background: Clonal hematopoiesis of indeterminate potential (CHIP) has been shown to increase all-cause mortality and risk of cardiomyopathy in patients with solid malignancies. CHIP has also been shown to increase T cell activation in heart failure patients. It is unclear whether CHIP can affect the risk of immune checkpoint inhibitor (ICI) myocarditis in patients with cancer treated with immunotherapy. Methods: We enrolled patients with solid tumors in a prospective study, determined CHIP status at time of enrollment through blood whole exome sequencing, and assessed incidence of ICI myocarditis from time of enrollment through December 1st, 2023. We performed a competing risk cox regression to evaluate the role of CHIP in ICI myocarditis, accounting for patient demographics, cardiac comorbidities, cardiotoxic cancer therapy, and dual ICI use in our covariates. We also generated cumulative incidence curves using subdistribution hazards to evaluate development of ICI myocarditis stratified by CHIP vs no CHIP. Chart review was performed to evaluate patient co-morbidities, lab values, imaging findings and outcomes. Results: Among the 88 patients receiving ICI therapy, average age was 67 ± 14 years, of which 50% harbored CHIP variants. Among all comorbidities, including diabetes, heart failure and obstructive coronary artery disease, only coronary artery calcifications were significantly increased in patients with CHIP. There were no statistically significant differences in cancer therapy or cardiovascular drugs between patients with and without CHIP. Among examined outcomes, patients with CHIP had a statistically higher rate of ICI myocarditis (overall: 57%, CHIP: 73% (32/44), no CHIP: 41% (18/44), p = 0.003) and death (CHIP: 60%, no CHIP 31%, p = 0.011). In a multivariate competing risk analysis, CHIP status doubled the risk of developing ICI myocarditis, similar to the risk of dual ICI use (CHIP status HR 2.74, 95% CI: 1.44–5.22, p = 0.002 vs dual ICI use HR 2.39, 95% CI: 1.11–5.14, p = 0.026). Conclusions: This study is the first to show that CHIP independently increases risk of ICI myocarditis, with implications for risk stratification of patients prior to ICI initiation and frequency of cardiac monitoring.


  • Open Access

    Somatic Variants Acquired Later in Life Associated with Thoracic Aortic Aneurysms: JAK2 V617F

    by Christina Waldron, Mohammad A. Zafar, Deqiong Ma, Hui Zhang, Daniel Dykas, Bulat A. Ziganshin, Andreea Popa, Alokkumar Jha, Jennifer M. Kwan, John A. Elefteriades

    The JAK2 V617F somatic variant is a well-known driver of myeloproliferative neoplasms (MPN) associated with an increased risk for athero-thrombotic cardiovascular disease. Recent studies have demonstrated its role in the development of thoracic aortic aneurysm (TAA). However, limited clinical information and level of JAK2 V617F burden have been provided for a comprehensive evaluation of potential confounders. A retrospective genotype-first study was conducted to identify carriers of the JAK2 V617F variant from an internal exome sequencing database in Yale DNA Diagnostics Lab. Additionally, the overall incidence of somatic variants in the JAK2 gene across various tissue types in the healthy population was carried out based on reanalysis of SomaMutDB and data from the UK Biobank (UKBB) cohort to compare our dataset to the population prevalence of the variant. In our database of 12,439 exomes, 594 (4.8%) were found to have a thoracic aortic aneurysm (TAA), and 12 (0.049%) were found to have a JAK2 V617F variant. Among the 12 JAK2 V617F variant carriers, five had a TAA (42%), among whom four had an ascending TAA and one had a descending TAA, with a variant allele fraction ranging from 11.2% to 20%. Among these five patients, 60% were female, and average age at diagnosis was 70 (49–79). The mean ascending aneurysm size was 5.05 cm (range 4.6–5.5 cm), and four patients had undergone surgical aortic replacement or repair. UKBB data revealed a positive correlation between the JAK2 V617F somatic variant and aortic valve disease (effect size 0.0086, p = 0.85) and TAA (effect size = 0.004, p = 0.92), although not statistically significant. An unexpectedly high prevalence of TAA in our dataset (5/594, 0.84%) is greater than the prevalence reported before for the general population, supporting its association with TAA. JAK2 V617F may contribute a meaningful proportion of otherwise unexplained aneurysm patients. Additionally, it may imply a potential JAK2-specific disease mechanism in the developmental of TAA, which suggests a possible target of therapy that warrants further investigation.


  • Open Access

    Impact of COVID-19 pandemic on physician-scientist trainees to faculty one year into the pandemic

    by Aleksandar Obradovic, Aleksandar Obradovic, Aleksandar Obradovic, Aleksandar Obradovic, Omar Toubat, Omar Toubat, Omar Toubat, Omar Toubat, Nathan W. Chen, Nathan W. Chen, et al.

    Purpose: Physician-scientists play a crucial role in advancing biomedical sciences. Proportionally fewer physicians are actively engaged in scientific pursuits, attributed to attrition in the training and retention pipeline. This national study evaluated the ongoing and longer-term impact of the COVID-19 pandemic on stress levels, research productivity, and optimism for physician-scientists at all levels of training. Methods: A multi-institutional cross-sectional survey of medical students, graduate students, and residents/fellows/junior faculty (RFJF) was conducted from April to August 2021 to assess the impact of COVID-19 on individual stress, productivity, and optimism. Multivariate regression analyses were performed to identify associated variables and unsupervised variable clustering techniques were employed to identify highly correlated responses. Results: A total 677 respondents completed the survey, representing different stages of physician-scientist training. Respondents report high levels of stress (medical students: 85%, graduate students: 63%, RFJF: 85%) attributed to impaired productivity concerns, concern about health of family and friends, impact on personal health and impairment in training or career development. Many cited impaired productivity (medical students: 65% graduate students: 79%, RFJF: 78%) associated with pandemic impacts on training, labs closures and loss of facility/resource access, and social isolation. Optimism levels were low (medical students: 37%, graduate students: 38% and RFJF: 39%) with females less likely to be optimistic and more likely to report concerns of long-term effects of COVID-19. Optimism about the future was correlated with not worrying about the long-term effects of COVID-19. Since the COVID-19 pandemic, all respondents reported increased prioritization of time with family/friends (67%) and personal health (62%) over career (25%) and research (24%). Conclusions: This national survey highlights the significant and protracted impact of the COVID-19 pandemic on stress levels, productivity, and optimism among physician-scientists and trainees. These findings underscore the urgent need for tailored support, including mental health, academic, and career development assistance for this biomedical workforce.


  • Open Access

    Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing

    by Marah Maayah, Scott Grubman, Stephanie Allen, Zachary Ye, Dae Yong Park, Evangelia Vemmou, Ilhan Gokhan, Wendy W. Sun, Stephen Possick, Jennifer M. Kwan, et al.

    Cardiac troponin (Tn) plays a central role in the evaluation of patients with angina presenting with acute coronary syndrome. The advent of high-sensitivity assays has improved the analytic sensitivity and precision of serum Tn measurement, but this advancement has come at the cost of poorer specificity. The role of clinical judgment is of heightened importance because, more so than ever, the interpretation of serum Tn elevation hinges on the careful integration of findings from electrocardiographic, echocardiographic, physical exam, interview, and other imaging and laboratory data to formulate a weighted differential diagnosis. A thorough understanding of the epidemiology, mechanisms, and prognostic implications of Tn elevations in each cardiac and non-cardiac etiology allows the clinician to better distinguish between presentations of myocardial ischemia and myocardial injury—an important discernment to make, as the treatment of acute coronary syndrome is vastly different from the workup and management of myocardial injury and should be directed at the underlying cause.